NIH, CDC, FDA increased SBIR/STTR proposal budget limit.

  • Friday, May 24, 2019 7:00 AM

Back in November of 2018, we noted that the SBIR/STTR Statute (15 U.S.C. §638) establishes a cap for the maximum dollar amount of SBIR and STTR awards, above which an agency must request an SBA-approved waiver, AND that as of 11/20/2018, agencies may issue a Phase I award (including modifications) up to $252,131 and a Phase II award (including modifications) up to $1,680,879 without seeking SBA approval.

Any award above those levels will require a waiver. Agencies considering this authority should review §7(i)(5) for additional information.

With the release of NIH, CDC, and FDA solicitations (PA-19-272), (PA-19-270), (PA-19-273), and (PA-19-271) for SBIR/STTR funding the funding lines have adjusted their budgets accordingly.

Total funding support (direct costs, indirect costs, fee) normally may not exceed $252,131 for Phase I awards and $1,680,879 for Phase II awards.

In addition, NIH has received a waiver from SBA, as authorized by statute, to exceed these total award amount hard caps for specific topics. The current list of approved topics can be found at https://sbir.nih.gov/funding#omni-sbir. Navigate to the “Program Descriptions and Research Topics” document, Appendix A or the “2019 SBA approved topics list for budget waivers”.

VIP: before adjusting your budget on your upcoming proposal, check with the participating SBIR funding agency to confirm budget adjustments.


Let us help you meet your M/WBE utilization goal. We can help you locate funding, apply for funding, and help organizations measure & report on outcomes. See our experience with grant writing and evaluation services HERE.
Related Posts
error: Content is protected !!